Zur Rose Group AG
A European e-commerce pharmacy providing an online platform for medicines and health.
ROSE | SW
Overview
Corporate Details
- ISIN(s):
- CH0042615283 (+1 more)
- LEI:
- 50670038OH136R5Z4663
- Country:
- Switzerland
- Address:
- Walzmühlestrasse 49, 8500 Frauenfeld
- Sector:
- Wholesale and retail trade
Description
DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-26 09:14 |
Aucune donnee concernant la boutique en ligne de produits cosmetiques et de soi…
|
French | 1.6 KB | ||
| 2022-01-20 07:00 |
Zur Rose Group: steady growth in a volatile market environment
|
English | 26.2 KB | ||
| 2022-01-10 07:00 |
Zur Rose Group nominates Rongrong Hu as director
|
English | 7.2 KB | ||
| 2021-12-09 07:01 |
Zur Rose Group successfully completed capital increase from authorised capital…
|
English | 3.8 KB | ||
| 2021-12-08 17:42 |
Zur Rose Group decides on capital increase from authorised capital and starts a…
|
English | 3.8 KB | ||
| 2021-10-28 07:00 |
Roche and the Zur Rose Group announce collaboration to offer innovative health …
|
English | 10.7 KB | ||
| 2021-10-21 07:00 |
Zur Rose Group: Board of Directors nominates Walter Oberhansli as Chairman and …
|
English | 8.8 KB | ||
| 2021-10-21 06:55 |
Zur Rose Group continues to grow strongly
|
English | 26.5 KB | ||
| 2021-08-18 07:00 |
Zur Rose Group accelerates growth in second quarter with revenue up 26 per cent
|
English | 39.7 KB | ||
| 2021-08-18 00:00 |
Presentation on half-year results 2021
|
English | 1.7 MB | ||
| 2021-08-18 00:00 |
Präsentation zum Halbjahresergebnis 2021
|
German | 1.7 MB | ||
| 2021-08-18 00:00 |
Half-Year Report 2021
|
English | 113.7 KB | ||
| 2021-08-18 00:00 |
Halbjahresbericht 2021
|
German | 122.6 KB | ||
| 2021-06-15 07:00 |
Zur Rose Group strengthens Group Management: Madhu Nutakki to become Chief Tech…
|
English | 7.8 KB | ||
| 2021-04-29 18:00 |
Annual General Meeting of Zur Rose Group AG: Shareholders approve all proposals
|
English | 8.6 KB |
Automate Your Workflow. Get a real-time feed of all Zur Rose Group AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Zur Rose Group AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Zur Rose Group AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 175,188.00 CHF |
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 28,818.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 34,500.00 CHF |
| 2025-05-19 | N/A | Non-Executive member | Buy | None | 14,040.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 9,142.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 1,035,000.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 46,400.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 10,315.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 8,616.00 CHF |
| 2025-05-15 | N/A | Executive member | Buy | None | 678,770.25 CHF |
Peer Companies
